Belite Bio Inc ADR [BLTE] stock prices are down -2.06% to $150.84 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BLTE shares have gain 10.91% over the last week, with a monthly amount glided 42.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Belite Bio Inc ADR [NASDAQ: BLTE] stock has seen the most recent analyst activity on December 02, 2025, when Mizuho upgraded its rating to a Outperform but kept the price target unchanged to $194 for it. On November 20, 2025, Mizuho initiated with a Neutral rating and assigned a price target of $105 on the stock. Maxim Group started tracking the stock assigning a Buy rating and suggested a price target of $60 on December 14, 2023. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $43 as its price target on July 28, 2023. SVB Securities started tracking with a Outperform rating for this stock on July 26, 2023, and assigned it a price target of $25. In a note dated August 01, 2022, H.C. Wainwright initiated an Buy rating and provided a target price of $58 on this stock.
The stock price of Belite Bio Inc ADR [BLTE] has been fluctuating between $49.00 and $154.99 over the past year. Currently, Wall Street analysts expect the stock to reach $193 within the next 12 months. Belite Bio Inc ADR [NASDAQ: BLTE] shares were valued at $150.84 at the most recent close of the market. An investor can expect a potential return of 27.95% based on the average BLTE price forecast.
Analyzing the BLTE fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.35 and Total Capital is -0.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 144.17 points at the first support level, and at 137.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 159.03, and for the 2nd resistance point, it is at 167.22.
Ratios To Look Out For
It’s worth pointing out that Belite Bio Inc ADR [NASDAQ:BLTE]’s Current Ratio is 34.37. Further, the Quick Ratio stands at 34.37.
Transactions by insiders
Recent insider trading involved Wan Shan Chen, Affiliate, that happened on Oct 17 ’25 when 9550.0 shares were purchased. affiliate, Wan Shan Chen completed a deal on Oct 16 ’25 to buy 1050.0 shares. Meanwhile, Officer, Director Hao-Yuan Chuang bought 70054.0 shares on Oct 13 ’25.
